Glycos selects Toyo as contractor for new biochemical plant


Toyo Engineering & Construction has entered into an agreement with Glycos Biotechnologies to provide engineering, procurement, and construction services for Glycos's new biochemical production facility in Johor, Malaysia.

The facility will be established in Bio XCell, a government-supported biotechnology park that focuses on advancements in industrial and healthcare biotechnology fields.

It will be used to produce isoprene biochemical, which is a key building block molecule used in the synthetic rubber market.

The plant is expected to have an initial production capacity of up to 30,000t/year, and is expected to achieve capacity of up to 90,000t/year by 2014.

Glycos will initially evaluate the ability of the new facility for producing industrial ethanol from crude glycerin.

It will then further validate the new facility's flexible technology platform at commercial scale using a range of feedstocks, including fatty acids.

Full production of its facility will follow with the production of isoprene from low-value renewable feedstocks readily available in Malaysia.

Bio-XCell CEO Rizatuddin Ramli said that, apart from human capital development and expanded investment opportunities, Glycos's technology will be a critical contributor to Malaysia's near and long-term industrial and biotechnology goals.

The construction of the plant is scheduled to be completed in the second quarter of 2013.

Glycos is also working closely with BiotechCorp to build a new biotechnology facility in Malaysia.